Safinamide as Add-On Therapy in Patients With Early Idiopathic Parkinson's Disease Treated With a Stable Dose of a Single Dopamine Agonist
Clinical trial NCT00643045 · COMPLETED
Trial details
- NCT number
- NCT00643045
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Primary completion
- 2006-01-01
- Enrollment
- 269
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.